| Unique ID issued by UMIN | UMIN000061913 |
|---|---|
| Receipt number | R000070844 |
| Scientific Title | Research on development of nutritional status estimation logic using urine tests and questionnaires and its applicability to specific health guidance |
| Date of disclosure of the study information | 2026/06/20 |
| Last modified on | 2026/06/15 15:03:53 |
Evaluative study on nutritional status estimation and specific health guidance program using urine tests and questionnaires
Urine & Questionnaire Nutrition Guidance Study
Research on development of nutritional status estimation logic using urine tests and questionnaires and its applicability to specific health guidance
Nutritional Estimation and Guidance Study
| Japan |
To evaluatively assess the validity of a nutrient dietary intake estimation logic combining instant urine test data and questionnaire responses, and to exploratorily evaluate the efficacy of an individualized dietary guidance program utilizing the logic.
| Medicine in general | Adult |
Others
NO
Efficacy, Feasibility
Efficacy
Exploratory
1. Validity of the dietary intake estimation logic (consistency and correlation between estimated nutrient intake and nutrient intake calculated from dietary photo records).
2. Feasibility of the specific health guidance program (changes from baseline to 3 months in urine test scores, weight, waist circumference, and BMI).
Changes in estimated dietary intake, changes in questionnaire scores related to dietary and lifestyle habits, and adherence status of dietary photo records
Interventional
Single arm
Non-randomized
Open -no one is blinded
Uncontrolled
1
Prevention
| Other |
During the 3-month study period, a total of 3 urine tests using the Yuurea app, dietary photo/weight/waist circumference recording on the eat+ app, 3 questionnaire responses, and a total of 3 individualized dietary guidance sessions by registered dietitians will be conducted.
| 20 | years-old | <= |
| Not applicable |
Male and Female
1. Individuals who understand the purpose of this study and voluntarily consent to participate.
2. Employees of the research sponsor (including those eligible for specific health guidance) or general public participants aged 20 and over.
1. Individuals taking diabetes medications (GLP-1 receptor agonists, insulin preparations, SGLT2 inhibitors, etc.).
2. Individuals taking antihypertensive drugs (ACE inhibitors, ARBs, diuretics, etc.).
3. Individuals with renal dysfunction or serious illness who are under dietary restrictions by a physician.
4. Individuals who find it difficult to operate smartphones, or who are expected to have difficulty continuing due to long-term business trips, etc.
130
| 1st name | Masaki |
| Middle name | |
| Last name | Takezawa |
Toyoda Gosei Co., Ltd.
New Value Creation Dept.
452-8564
1 Haruhi-nagahata, Kiyosu-shi, Aichi
052-400-1151
info@yuurea.co.jp
| 1st name | Masaki |
| Middle name | |
| Last name | Takezawa |
Toyoda Gosei Co., Ltd.
New Value Creation Dept.
452-8564
1 Haruhi-nagahata, Kiyosu-shi, Aichi
052-400-1151
info@yuurea.co.jp
Toyoda Gosei Co., Ltd.
Toyoda Gosei Co., Ltd.
Profit organization
Research Ethics Committee of Yuurea Co., Ltd.
3F Nagono Campus, 2-14-1 Nagono, Nishi-ku, Nagoya-shi, Aichi
-
-
NO
| 2026 | Year | 06 | Month | 20 | Day |
Unpublished
Preinitiation
| 2026 | Year | 06 | Month | 10 | Day |
| 2026 | Year | 06 | Month | 10 | Day |
| 2026 | Year | 06 | Month | 20 | Day |
| 2027 | Year | 03 | Month | 31 | Day |
| 2027 | Year | 03 | Month | 31 | Day |
| 2027 | Year | 03 | Month | 31 | Day |
| 2027 | Year | 03 | Month | 31 | Day |
| 2026 | Year | 06 | Month | 15 | Day |
| 2026 | Year | 06 | Month | 15 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000070844